InsidersTradesSigma
Browse the complete record of transactions filed by Holmen Bob, 董事. Director active across 1 company, notably Sensei Biotherapeutics, Inc.. Cumulatively, 1 filings have been recorded. History available since 10 June 2022. The latest transaction was filed on 10 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Bob Holmen is a Board Member at Sensei Biotherapeutics, Inc. He plays a key role in the governance of the company, which focuses on developing biopharmaceutical solutions. His experience in the sector is essential in guiding research and development initiatives and ensuring that the company remains at the forefront of innovation.